Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients
Clinical trial NCT03374839 · UNKNOWN
Trial details
- NCT number
- NCT03374839
- Sponsor
- Nantes University Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-12
- Primary completion
- 2024-01-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.